Pharmacy Benefits Management

April 9, 2014 | Anthony Brino

New public insurance exchange enrollees are starting to use their prescription drug benefits, and so far their per-member costs are looking higher than in the average commercial plan.

April 7, 2014 | Frank Irving

Patients don't fill first-time prescriptions nearly one-third of the time, which makes "nonadherence" an important factor working against proper disease management.

March 24, 2014 | Anthony Brino

Health insurers can expect an increasing number of consumer education challenges around prescription drug management, as utilization controls are more prevalent in public exchange plans than in typical group insurance.

March 12, 2014 | Anthony Brino

The drug formularies of some small group health plans in two states don't meet essential health benefit benchmarks, a new study has found, leaving researchers pointing to a solution that may be as complex as benefit mandates.

March 10, 2014 | Anthony Brino

Under pressure from the industry and Congress, the Centers for Medicare & Medicaid Services is withdrawing several proposed changes to the Medicare drug program, but still charging ahead with others that could prove disruptive.

March 3, 2014 | Anthony Brino

A large group of health, pharma and payer organizations are hoping to stop what some think are the most pernicious changes to Medicare Part D in the program's history.

February 26, 2014 | Anthony Brino

The Centers for Medicare & Medicaid Services' latest proposals to curb the overuse of painkillers could have a lot of unintended consequences, hospice and palliative care advocates are warning.

February 13, 2014 | Anthony Brino

Between 20 years researching leukemia at Harvard and four years directing Merck's oncology program, Gary Gilliland, MD, has seen a lot of ups and even more downs. Now, as the head of precision medicine at Penn, he's fairly optimistic about emerging therapies like immunologics, but just as concerned about how to pay for them.

January 8, 2014 | Anthony Brino

With the cost of copayments for cancer pharmaceuticals varying widely, some patients end up skipping doses or stopping some treatments altogether, according to a new study.

January 7, 2014 | Anthony Brino

The Centers for Medicare & Medicaid Services is proposing a number of new tweaks and more stringent requirements for Medicare Part D, hoping to save more than $1 billion over five years.

December 31, 2013 | Kelsey Brimmer

Global pharmaceuticals and healthcare products company Abbott Laboratories has agreed to pay the United States $5.475 million to resolve allegations that the company violated the False Claims Act by paying improper kickbacks to induce doctors to use some of its products.

December 2, 2013 | Mary Mosquera

Patients with diabetes who received their heart medications by mail were less likely to visit the emergency room than those who picked up prescriptions in person, a study by Kaiser Permanente found.

Advertisement. Closing in 15 seconds.